Jens Jakob

2.6k total citations · 1 hit paper
68 papers, 1.2k citations indexed

About

Jens Jakob is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Jens Jakob has authored 68 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Pulmonary and Respiratory Medicine, 26 papers in Oncology and 17 papers in Surgery. Recurrent topics in Jens Jakob's work include Sarcoma Diagnosis and Treatment (47 papers), Vascular Tumors and Angiosarcomas (17 papers) and Gastrointestinal Tumor Research and Treatment (13 papers). Jens Jakob is often cited by papers focused on Sarcoma Diagnosis and Treatment (47 papers), Vascular Tumors and Angiosarcomas (17 papers) and Gastrointestinal Tumor Research and Treatment (13 papers). Jens Jakob collaborates with scholars based in Germany, Italy and United Kingdom. Jens Jakob's co-authors include Peter Hohenberger, Alessandro Gronchi, Ulrich Ronellenfitsch, Marco Fiore, Paolo G. Casali, Andrew Hayes, Chiara Mussi, Bernd Kasper, D. Strauß and Milena Szacht and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer.

In The Last Decade

Jens Jakob

62 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Variability in Patterns of Recurrence After Resection of Primary Retroperitoneal Sarcoma (RPS)

2016 336 citations Peter Hohenberger, Jens Jakob et al. profile →

Peers

Countries citing papers authored by Jens Jakob

Since Specialization

Citations

This map shows the geographic impact of Jens Jakob's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jens Jakob with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jens Jakob more than expected).

Fields of papers citing papers by Jens Jakob

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jens Jakob. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jens Jakob. The network helps show where Jens Jakob may publish in the future.

Co-authorship network of co-authors of Jens Jakob

This figure shows the co-authorship network connecting the top 25 collaborators of Jens Jakob. A scholar is included among the top collaborators of Jens Jakob based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jens Jakob. Jens Jakob is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	An analysis of the distribution of bone and soft tissue sarcoma diagnoses and their disparities in Southwest Germany: a multicenter approach 2025 ·Frontiers in Oncology ·(unknown), (unknown), (unknown), Adrien Daigeler, (unknown), Jens Jakob, Bernd Kasper, Gerlinde Egerer, Leonidas Apostolidis, David Braig, Simone Hettmer, Claudia Blattmann, (unknown), Lars Zender, (unknown)	0
2	Selective internal radiation with Y-90 resin microspheres (SIRT) for liver metastases of gastro-intestinal stromal tumors (GIST) resistant to tyrosine kinase inhibitor (TKI) therapy 2025 ·British Journal of Cancer ·Peter Hohenberger, Nils Rathmann, Karen A. Büsing, (unknown), Jens Jakob, Daniel Pink, Eva Wardelmann, Stefan O. Schoenberg, Steffen J. Diehl	0
3	Postoperative drainage management and wound complications following resection of lower limb soft tissue tumors: a retrospective cohort study 2023 ·Langenbeck s Archives of Surgery ·Andreas L. H. Gerken, (unknown), (unknown), Cui Yang, Julia Hardt, (unknown), Peter Hohenberger, Christel Weiß, Christoph Reißfelder, Jens Jakob	2
4	Molecular and Pathological Profiling of Corresponding Treatment-Naïve and Neoadjuvant Pazopanib-Treated High-Risk Soft Tissue Sarcoma Samples of the GISG-04/NOPASS Study 2021 ·Biology ·Timo Gaiser, Christian Sauer, Alexander Marx, Jens Jakob, Bernd Kasper, Peter Hohenberger, Daniela Hirsch, Ulrich Ronellenfitsch	1
5	Surgical approaches for retroperitoneal tumors 2021 ·SHILAP Revista de lepidopterología ·Ulrich Ronellenfitsch, Jens Jakob	1
6	Fusion imaging to evaluate the radiographic anatomical relationship between primary tumors and local recurrences in retroperitoneal soft tissue sarcoma 2020 ·Surgical Oncology ·(unknown), S. Janssen, Nikolaos Vassos, Peter Hohenberger, Anna Simeonova-Chergou, Frederik Wenz, Holger Haubenreisser, Jens Jakob	2
7	Medical Care and Survival of Soft-Tissue and Bone Sarcoma Patients: Results and Methodological Aspects of a German Subnational Cohort Study Based on Administrative Healthcare Data 2020 ·Oncology Research and Treatment ·Olaf Schoffer, Martin Roessler, Thomas Datzmann, Dimosthenis Andreou, Jens Jakob, Martin Eichler, Stephan Richter, Markus K. Schuler, Jochen Schmitt	1
8	Neoadjuvant Pazopanib Treatment in High-Risk Soft Tissue Sarcoma: A Quantitative Dynamic 18F-FDG PET/CT Study of the German Interdisciplinary Sarcoma Group 2019 ·Cancers ·Christos Sachpekidis, Ioannis Karampinis, Jens Jakob, Bernd Kasper, Kai Nowak, Lothar R. Pilz, Ulrike Attenberger, Timo Gaiser, Hans‐Günter Derigs, Matthias Schwarzbach, Peter Hohenberger, Antonia Dimitrakopoulou‐Strauss, Ulrich Ronellenfitsch	10
9	Multidisciplinary Tumor Board Recommendations for Oligometastatic Malignancies: A Prospective Single-Center Analysis 2019 ·Oncology Research and Treatment ·Christian Galata, Elisabeth Wimmer, Bernd Kasper, Frederik Wenz, Christoph Reißfelder, Jens Jakob	11
10	Preoperative Pazopanib in High-Risk Soft Tissue Sarcoma: Phase II Window-of Opportunity Study of the German Interdisciplinary Sarcoma Group (NOPASS/GISG-04) 2019 ·Annals of Surgical Oncology ·Ulrich Ronellenfitsch, Ioannis Karampinis, Antonia Dimitrakopoulou‐Strauss, Christos Sachpekidis, Jens Jakob, Bernd Kasper, Kai Nowak, Lothar R. Pilz, Ulrike Attenberger, Timo Gaiser, (unknown), Matthias Schwarzbach, Peter Hohenberger	12
11	Impact of preoperative treatment on the CINSARC prognostic signature: translational research results from a phase 1 trial of the German Interdisciplinary Sarcoma Group (GISG 03) 2019 ·Strahlentherapie und Onkologie ·Jens Jakob, Tom Lesluyes, Anna Simeonova-Chergou, Frederik Wenz, Peter Hohenberger, Frédéric Chibon, Sophie Le Guellec	1
12	Combined sunitinib and radiation therapy for preoperative treatment of soft tissue sarcoma: results of a phase I trial of the German interdisciplinary sarcoma group (GISG-03) 2016 ·Radiation Oncology ·Jens Jakob, (unknown), Bernd Kasper, Ulrich Ronellenfitsch, Geraldine Rauch, Frederik Wenz, Peter Hohenberger	23
13	Interdisziplinäre Behandlung der Weichgewebesarkome der Extremitäten 2014 ·Der Chirurg ·Jens Jakob, Thomas Henzler, Bernd Kasper, Alexander Marx, Peter Hohenberger	3
14	Phase I trial of concurrent sunitinib and radiation therapy as preoperative treatment for soft tissue sarcoma 2013 ·BMJ Open ·Jens Jakob, Geraldine Rauch, Frederik Wenz, Peter Hohenberger	10
15	Impact of hyperthermic isolated limb perfusion on tumour oxygenation in soft tissue sarcoma 2012 ·International Journal of Hyperthermia ·Jens Jakob, (unknown), Christel Weiß, Peter Hohenberger	5
16	Managing sensitive phenotypic data and biomaterial in large-scale collaborative psychiatric genetic research projects: practical considerations 2012 ·Molecular Psychiatry ·(unknown), (unknown), (unknown), (unknown), Monika Budde, (unknown), Daniela Reich‐Erkelenz, Jens Jakob, Peter Falkai, Otto Rienhoff, (unknown), Urs Heilbronner, Thomas G. Schulze	12
17	Preoperative Intensity-Modulated Radiotherapy Combined with Temozolomide for Locally Advanced Soft-Tissue Sarcoma 2009 ·International Journal of Radiation OncologyBiologyPhysics ·Jens Jakob, Frederik Wenz, Dietmar Dinter, Philipp Ströbel, Peter Hohenberger	13
18	Seasonal vertical distribution, abundance, biomass, and biometrical relationships of ostracods in Golfo Dulce, Pacific coast of Costa Rica 2008 ·Revista de Biología Tropical ·Álvaro Moráles-Ramírez, Jens Jakob	9
19	Clinical Pathways in surgery—should we introduce them into clinical routine? A review article 2008 ·Langenbeck s Archives of Surgery ·Ulrich Ronellenfitsch, (unknown), Jens Jakob, Stefan Post, Peter Hohenberger, Matthias Schwarzbach	51
20	Meine Erfahrungen als Tutorin einer Anamnesegruppe 2001 ·Diana Mitter, Jens Jakob	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact